Valuation : Beijing Airdoc Technology Co., Ltd.

Market Cap 705M 824M 105M 90.43M 85.07M 77.56M 146M 9.97B 147M 1.01B 392M 5.06B 394M 386M 16.83B P/E 2026 *
-18.8x
P/E 2027 * -349x
Enterprise Value 705M 824M 105M 90.43M 85.07M 77.56M 146M 9.97B 147M 1.01B 392M 5.06B 394M 386M 16.83B EV / Sales 2026 *
2.8x
EV / Sales 2027 * -
Free-Float
32.07%
Yield 2026 *
-
Yield 2027 * -
1 day-5.41%
1 week-14.99%
Current month-5.41%
1 month-16.82%
3 months-20.32%
6 months-29.81%
Current year-28.83%
1 week 8.12
Extreme 8.12
9.57
1 month 8.12
Extreme 8.12
10.4
Current year 8.12
Extreme 8.12
13.77
1 year 8.12
Extreme 8.12
16
3 years 8.12
Extreme 8.12
18.38
5 years 7.88
Extreme 7.88
74.95
10 years 7.88
Extreme 7.88
74.95
Manager TitleAgeSince
Chief Executive Officer 43 2015-09-08
General Counsel - 2021-02-28
Corporate Secretary - 2022-01-18
Director TitleAgeSince
Chairman 43 2015-09-08
Director/Board Member 63 2020-12-24
Director/Board Member 53 2020-12-24
Date Insider Type Main position Quantity % Market Cap. Importance
5/29/26 Other

Chief Executive Officer

-165,400 0.1597%
1/20/26 Other

Chief Executive Officer

418,500 0.4041%
9/24/25 Other

Chief Executive Officer

35,000 0.0338%
Change 5-day change 1-year change 3-year change Capi.($)
-5.41%-14.99%-42.06%-25.91% 111M
-2.26%+12.38%+3.73%+33.79% 46.26B
-1.66%-8.79%-40.96%+140.62% 13.42B
-0.75%+6.24%-11.64%+71.35% 5.94B
+0.08%+0.46%+60.10% - 4.38B
+3.41%-10.89% - - 1.96B
-1.85%-0.43%+5.89%-39.31% 1.6B
0.00%-2.04%-33.49% - 1.11B
+0.20%-2.12%+37.20%+150.74% 1.01B
+4.10%+1.54%+55.24%+63.83% 995M
Average -0.27%-0.87%+3.78%+56.44% 7.68B
Weighted average by Cap. -0.73%+7.96%-1.65%+58.03%

Financials

2026 *2027 *
Net sales 252M 294M 37.55M 32.33M 30.42M 27.73M 52.08M 3.57B 52.54M 360M 140M 1.81B 141M 138M 6.02B -
Net income -39M -45.57M -5.81M -5M -4.71M -4.29M -8.06M -552M -8.13M -55.78M -21.67M -280M -21.82M -21.34M -931M -
Net Debt - -
Logo Beijing Airdoc Technology Co., Ltd.
Beijing Airdoc Technology Co Ltd is a China-based company primarily engaged in providing artificial intelligence (AI)-empowered retina-based early detection, diagnosis and health risk assessment solutions. The Company’s main products include Myopia Prevention and Control AI (PBM-AI), Retinal Detection AI (Retina AI) and Stress Resilience Monitoring AI (Neuro-AI). The Company offers health risk assessment solutions with the ability to detect risk indicators, including risk assessments of retinal abnormalities, retinal vascular diseases, vitreous abnormalities, retinal tumors, optic nerve pathologies, macular diseases, congenital anomalies of the retina, cardiovascular disease and anemia. The Company conducts its business in the domestic and overseas markets.
Employees
181
Date Price Change Volume
26-09-01 HK$8.135 -5.41% 88,000
26-08-31 HK$8.600 -9.66% 277,300
26-08-28 HK$9.520 0.00% 0
26-08-27 HK$9.520 0.00% 0
26-08-26 HK$9.520 -0.52% 500
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.974CNY
Average target price
11.22CNY
Spread / Average Target
+60.88%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2251 Stock